APRETUDE 200 MG/ML SUS INJ LIB PROL IM CT 25 FA VD AMB X 3 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1010703600020 -
GGREM
510623100060201 -
Código de barras
7896015593261
O que a fonte publica
- Detentor do registro
- GLAXOSMITHKLINE BRASIL LTDA
- Princípios ativos
- CABOTEGRAVIR
- Embalagem
- 200 MG/ML SUS INJ LIB PROL IM CT 25 FA VD AMB X 3 ML
- Tipo de produto
- Novo
- Classe terapêutica
- J5C5 - ANTIVIRAIS HIV, INIBIDORES DA INTEGRASE
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "APRETUDE 200 MG/ML SUS INJ LIB PROL IM CT 25 FA VD AMB X 3 ML",
"holder": "GLAXOSMITHKLINE BRASIL LTDA",
"stripe": null,
"barcodes": [
"7896015593261"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "510623100060201",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.247.743/0001-10",
"priceRegime": "Regulado",
"productName": "APRETUDE",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "200 MG/ML SUS INJ LIB PROL IM CT 25 FA VD AMB X 3 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "196446.79",
"icms-12": "223235.06",
"icms-17": "236682.83",
"icms-18": "239569.22",
"icms-19": "242526.92",
"icms-20": "245558.49",
"icms-21": "248666.87",
"icms-22": "251854.80",
"icms-23": "255125.64",
"icms-17.5": "238117.28",
"icms-19.5": "244033.27",
"icms-20.5": "247102.95",
"icms-22.5": "253479.81",
"icms-12-alc": "199317.07",
"icms-17-alc": "211323.90",
"icms-18-alc": "213901.09",
"icms-19-alc": "216541.73",
"icms-20-alc": "219248.57",
"icms-21-alc": "222023.97",
"icms-22-alc": "224870.28",
"icms-23-alc": "227790.66",
"withoutTaxes": "175398.89",
"icms-17.5-alc": "212604.73",
"icms-19.5-alc": "217886.80",
"icms-20.5-alc": "220627.43",
"icms-22.5-alc": "226321.04"
},
"pisCofinsList": "Negativa",
"substanceText": "CABOTEGRAVIR",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "263526.37",
"icms-12": "299461.88",
"icms-17": "317501.59",
"icms-18": "321373.58",
"icms-19": "325341.23",
"icms-20": "329407.97",
"icms-21": "333577.75",
"icms-22": "337854.25",
"icms-23": "342241.96",
"icms-17.5": "319425.85",
"icms-19.5": "327361.94",
"icms-20.5": "331479.81",
"icms-22.5": "340034.14",
"icms-12-alc": "275544.16",
"icms-17-alc": "292142.89",
"icms-18-alc": "295705.71",
"icms-19-alc": "299356.24",
"icms-20-alc": "303098.29",
"icms-21-alc": "306935.11",
"icms-22-alc": "310869.97",
"icms-23-alc": "314907.22",
"withoutTaxes": "242478.68",
"icms-17.5-alc": "293913.57",
"icms-19.5-alc": "301215.72",
"icms-20.5-alc": "305004.48",
"icms-22.5-alc": "312875.56"
},
"invalidBarcodes": [],
"activeSubstances": [
"CABOTEGRAVIR"
],
"therapeuticClass": "J5C5 - ANTIVIRAIS HIV, INIBIDORES DA INTEGRASE",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1010703600020",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "J5C5",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:510623100060201"